Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia

Mark D. DeBoer, Xia Zhu Xin, Peter Levasseur, Michael M. Meguid, Susumu Suzuki, Akio Inui, John E. Taylor, Heather A. Halem, Jesse Z. Dong, Rakesh Datta, Michael D. Culler, Daniel Marks

Research output: Contribution to journalArticle

146 Citations (Scopus)

Abstract

Cancer cachexia is a debilitating syndrome of anorexia and loss of lean body mass that accompanies many malignancies. Ghrelin is an orexigenic hormone with a short half-life that has been shown to improve food intake and weight gain in human and animal subjects with cancer cachexia. We used a rat model of cancer cachexia and administered human ghrelin and a synthetic ghrelin analog BIM-28131 via continuous infusion using sc osmotic minipumps. Tumorimplanted rats receiving human ghrelin or BIM-28131 exhibited a significant increase in food consumption and weight gain vs. saline-treated animals. We used dual-energy x-ray absorptiometry scans to show that the increased weight was due to maintenance of lean mass vs. a loss of lean mass in saline-treated animals. Also, BIM-28131 significantly limited the loss of fat mass normally observed in tumor-implanted rats. We further performed real-time PCR analysis of the hypothalami and brainstems and found that ghrelin-treated animals exhibited a significant increase in expression of orexigenic peptides agouti-related peptide and neuropeptide Y in the hypothalamus and a significant decrease in the expression of IL-1 receptor-I transcript in the hypothalamus and brainstem. We conclude that ghrelin and a synthetic ghrelin receptor agonist improve weight gain and lean body mass retention via effects involving orexigenic neuropeptides and antiinflammatory changes.

Original languageEnglish (US)
Pages (from-to)3004-3012
Number of pages9
JournalEndocrinology
Volume148
Issue number6
DOIs
StatePublished - Jun 2007

Fingerprint

Cachexia
Ghrelin
Eating
Hypothalamus
Weight Gain
Neoplasms
Brain Stem
Therapeutics
Artificial Receptors
Ghrelin Receptor
Peptides
Interleukin-1 Receptors
Neuropeptide Y
Anorexia
Neuropeptides
Half-Life
Real-Time Polymerase Chain Reaction
Anti-Inflammatory Agents
Fats
Maintenance

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. / DeBoer, Mark D.; Xin, Xia Zhu; Levasseur, Peter; Meguid, Michael M.; Suzuki, Susumu; Inui, Akio; Taylor, John E.; Halem, Heather A.; Dong, Jesse Z.; Datta, Rakesh; Culler, Michael D.; Marks, Daniel.

In: Endocrinology, Vol. 148, No. 6, 06.2007, p. 3004-3012.

Research output: Contribution to journalArticle

DeBoer, MD, Xin, XZ, Levasseur, P, Meguid, MM, Suzuki, S, Inui, A, Taylor, JE, Halem, HA, Dong, JZ, Datta, R, Culler, MD & Marks, D 2007, 'Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia', Endocrinology, vol. 148, no. 6, pp. 3004-3012. https://doi.org/10.1210/en.2007-0016
DeBoer, Mark D. ; Xin, Xia Zhu ; Levasseur, Peter ; Meguid, Michael M. ; Suzuki, Susumu ; Inui, Akio ; Taylor, John E. ; Halem, Heather A. ; Dong, Jesse Z. ; Datta, Rakesh ; Culler, Michael D. ; Marks, Daniel. / Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. In: Endocrinology. 2007 ; Vol. 148, No. 6. pp. 3004-3012.
@article{fe277bf74594455baa30fc6435d948e2,
title = "Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia",
abstract = "Cancer cachexia is a debilitating syndrome of anorexia and loss of lean body mass that accompanies many malignancies. Ghrelin is an orexigenic hormone with a short half-life that has been shown to improve food intake and weight gain in human and animal subjects with cancer cachexia. We used a rat model of cancer cachexia and administered human ghrelin and a synthetic ghrelin analog BIM-28131 via continuous infusion using sc osmotic minipumps. Tumorimplanted rats receiving human ghrelin or BIM-28131 exhibited a significant increase in food consumption and weight gain vs. saline-treated animals. We used dual-energy x-ray absorptiometry scans to show that the increased weight was due to maintenance of lean mass vs. a loss of lean mass in saline-treated animals. Also, BIM-28131 significantly limited the loss of fat mass normally observed in tumor-implanted rats. We further performed real-time PCR analysis of the hypothalami and brainstems and found that ghrelin-treated animals exhibited a significant increase in expression of orexigenic peptides agouti-related peptide and neuropeptide Y in the hypothalamus and a significant decrease in the expression of IL-1 receptor-I transcript in the hypothalamus and brainstem. We conclude that ghrelin and a synthetic ghrelin receptor agonist improve weight gain and lean body mass retention via effects involving orexigenic neuropeptides and antiinflammatory changes.",
author = "DeBoer, {Mark D.} and Xin, {Xia Zhu} and Peter Levasseur and Meguid, {Michael M.} and Susumu Suzuki and Akio Inui and Taylor, {John E.} and Halem, {Heather A.} and Dong, {Jesse Z.} and Rakesh Datta and Culler, {Michael D.} and Daniel Marks",
year = "2007",
month = "6",
doi = "10.1210/en.2007-0016",
language = "English (US)",
volume = "148",
pages = "3004--3012",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia

AU - DeBoer, Mark D.

AU - Xin, Xia Zhu

AU - Levasseur, Peter

AU - Meguid, Michael M.

AU - Suzuki, Susumu

AU - Inui, Akio

AU - Taylor, John E.

AU - Halem, Heather A.

AU - Dong, Jesse Z.

AU - Datta, Rakesh

AU - Culler, Michael D.

AU - Marks, Daniel

PY - 2007/6

Y1 - 2007/6

N2 - Cancer cachexia is a debilitating syndrome of anorexia and loss of lean body mass that accompanies many malignancies. Ghrelin is an orexigenic hormone with a short half-life that has been shown to improve food intake and weight gain in human and animal subjects with cancer cachexia. We used a rat model of cancer cachexia and administered human ghrelin and a synthetic ghrelin analog BIM-28131 via continuous infusion using sc osmotic minipumps. Tumorimplanted rats receiving human ghrelin or BIM-28131 exhibited a significant increase in food consumption and weight gain vs. saline-treated animals. We used dual-energy x-ray absorptiometry scans to show that the increased weight was due to maintenance of lean mass vs. a loss of lean mass in saline-treated animals. Also, BIM-28131 significantly limited the loss of fat mass normally observed in tumor-implanted rats. We further performed real-time PCR analysis of the hypothalami and brainstems and found that ghrelin-treated animals exhibited a significant increase in expression of orexigenic peptides agouti-related peptide and neuropeptide Y in the hypothalamus and a significant decrease in the expression of IL-1 receptor-I transcript in the hypothalamus and brainstem. We conclude that ghrelin and a synthetic ghrelin receptor agonist improve weight gain and lean body mass retention via effects involving orexigenic neuropeptides and antiinflammatory changes.

AB - Cancer cachexia is a debilitating syndrome of anorexia and loss of lean body mass that accompanies many malignancies. Ghrelin is an orexigenic hormone with a short half-life that has been shown to improve food intake and weight gain in human and animal subjects with cancer cachexia. We used a rat model of cancer cachexia and administered human ghrelin and a synthetic ghrelin analog BIM-28131 via continuous infusion using sc osmotic minipumps. Tumorimplanted rats receiving human ghrelin or BIM-28131 exhibited a significant increase in food consumption and weight gain vs. saline-treated animals. We used dual-energy x-ray absorptiometry scans to show that the increased weight was due to maintenance of lean mass vs. a loss of lean mass in saline-treated animals. Also, BIM-28131 significantly limited the loss of fat mass normally observed in tumor-implanted rats. We further performed real-time PCR analysis of the hypothalami and brainstems and found that ghrelin-treated animals exhibited a significant increase in expression of orexigenic peptides agouti-related peptide and neuropeptide Y in the hypothalamus and a significant decrease in the expression of IL-1 receptor-I transcript in the hypothalamus and brainstem. We conclude that ghrelin and a synthetic ghrelin receptor agonist improve weight gain and lean body mass retention via effects involving orexigenic neuropeptides and antiinflammatory changes.

UR - http://www.scopus.com/inward/record.url?scp=34250888937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250888937&partnerID=8YFLogxK

U2 - 10.1210/en.2007-0016

DO - 10.1210/en.2007-0016

M3 - Article

C2 - 17347304

AN - SCOPUS:34250888937

VL - 148

SP - 3004

EP - 3012

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -